Endari

Sickle Cell Disease: After Years Of Neglect Some Promise For Sufferers
Forbes
Mon, 02/17/20 - 10:26 am
sickle cell disease
Oxbryta
Adakveo
Endari
olinciguat
CRISPR
Trifecta of sickle cell disease therapies extend life expectancy, but are not cost-effective — ICER
Endpoints
Fri, 01/24/20 - 10:30 am
ICER
sickle cell disease
Novartis
Adakveo
Global Blood Therapeutics
Oxbryta
Emmaus Life Sciences
Endari
Emmaus tries to move forwards by reversing
EP Vantage
Thu, 06/13/19 - 10:06 am
Emmaus Life Sciences
Endari
sickle cell disease